NASDAQ:SAVA

Cassava Sciences Stock Earnings Reports

etoro logo Buy SAVA
*Your capital is at risk
$2.78
+0.0200 (+0.725%)
At Close: Nov 17, 2025

Cassava Sciences Earnings Calls

Sep 30, 2025
-$0.220 (18.52%)
Release date Nov 12, 2025
EPS estimate -$0.270
EPS actual -$0.220
EPS Surprise 18.52%
Revenue estimate -
Revenue actual 840K
Jun 30, 2025
Release date Aug 14, 2025
EPS estimate -
EPS actual -$0.180
Revenue estimate -
Revenue actual -
Mar 31, 2025
Release date May 08, 2025
EPS estimate -
EPS actual -$0.480
Revenue estimate -
Revenue actual -
Dec 31, 2024
-$0.570 (16.18%)
Release date Mar 03, 2025
EPS estimate -$0.680
EPS actual -$0.570
EPS Surprise 16.18%
Revenue estimate -
Revenue actual -

Last 4 Quarters for Cassava Sciences

Below you can see how SAVA performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Dec 31, 2024 Beat
Release date Mar 03, 2025
Price on release $2.48
EPS estimate -$0.680
EPS actual -$0.570
EPS surprise 16.18%
Date Price
Feb 25, 2025 $2.42
Feb 26, 2025 $2.30
Feb 27, 2025 $2.60
Feb 28, 2025 $2.40
Mar 03, 2025 $2.48
Mar 04, 2025 $2.68
Mar 05, 2025 $2.76
Mar 06, 2025 $2.82
Mar 07, 2025 $2.81
4 days before 2.48%
4 days after 13.31%
On release day 8.06%
Change in period 16.12%
Mar 31, 2025
Release date May 08, 2025
Price on release $1.70
EPS estimate -
EPS actual -$0.480
Date Price
May 02, 2025 $1.61
May 05, 2025 $1.60
May 06, 2025 $1.51
May 07, 2025 $1.56
May 08, 2025 $1.70
May 09, 2025 $1.77
May 12, 2025 $1.83
May 13, 2025 $1.86
May 14, 2025 $1.88
4 days before 5.59%
4 days after 10.59%
On release day 4.12%
Change in period 16.77%
Jun 30, 2025
Release date Aug 14, 2025
Price on release $2.41
EPS estimate -
EPS actual -$0.180
Date Price
Aug 08, 2025 $2.18
Aug 11, 2025 $2.25
Aug 12, 2025 $2.32
Aug 13, 2025 $2.28
Aug 14, 2025 $2.41
Aug 15, 2025 $2.34
Aug 18, 2025 $2.27
Aug 19, 2025 $2.19
Aug 20, 2025 $2.14
4 days before 10.55%
4 days after -11.20%
On release day -2.90%
Change in period -1.83%
Sep 30, 2025 Beat
Release date Nov 12, 2025
Price on release $3.26
EPS estimate -$0.270
EPS actual -$0.220
EPS surprise 18.52%
Date Price
Nov 06, 2025 $2.96
Nov 07, 2025 $2.96
Nov 10, 2025 $3.03
Nov 11, 2025 $3.11
Nov 12, 2025 $3.26
Nov 13, 2025 $2.94
Nov 14, 2025 $2.76
Nov 17, 2025 $2.78
4 days before 10.14%
4 days after -14.72%
On release day -9.82%
Change in period -6.08%

Cassava Sciences Earnings History

Earnings Calendar

FAQ

When is the earnings report for SAVA?
Cassava Sciences (SAVA) has scheduled its earnings report for Mar 02, 2026 before the markets open.

What is the SAVA price-to-earnings (P/E) ratio?
SAVA P/E ratio as of Nov 17, 2025 (TTM) is -1.34.

What is the SAVA EPS forecast?
The forecasted EPS (Earnings Per Share) for Cassava Sciences (SAVA) for the first fiscal quarter 2025 is $.

What are Cassava Sciences's retained earnings?
On its balance sheet, Cassava Sciences reported retained earnings of $840.00 thousand for the latest quarter ending Sep 30, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE